Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Chunxiao Ying"'
Publikováno v:
Emergency Medicine International, Vol 2022 (2022)
Purpose. This study aims to observe the effect of optimized individualized nursing care applied to intensive care unit (ICU) patients with severe pneumonia (SP). Methods. 440 patients with SP admitted to the ICU of our hospital from January 2019 to J
Externí odkaz:
https://doaj.org/article/7daa7601b99047219a5d4a401c09e384
Genotyping and Quantifying Lyme Pathogen Strains by Deep Sequencing of the Outer Surface Protein C (
Autor:
Lia, Di, Zhenmao, Wan, Saymon, Akther, Chunxiao, Ying, Amanda, Larracuente, Li, Li, Chong, Di, Roy, Nunez, D Moses, Cucura, Noel L, Goddard, Konstantino, Krampis, Wei-Gang, Qiu
Publikováno v:
Journal of clinical microbiology. 56(11)
A mixed infection of a single tick or host by Lyme disease spirochetes is common and a unique challenge for the diagnosis, treatment, and surveillance of Lyme disease. Here, we describe a novel protocol for differentiating Lyme strains on the basis o
Autor:
Konstantinos Krampis, Lia Di, Wei-Gang Qiu, Chunxiao Ying, Noel L. Goddard, D. Moses Cucura, Li Li, Roy E. Nunez, Saymon Akther, Amanda Larracuente, Zhenmao Wan, Chong Di
Mixed infection of a single tick or host by Lyme disease spirochetes is common and a unique challenge for diagnosis, treatment, and surveillance of Lyme disease. Here we describe a novel protocol for differentiating Lyme strains based on deep sequenc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ac2a12ef0969d26ed405b3459d8be81b
https://doi.org/10.1101/332072
https://doi.org/10.1101/332072
Publikováno v:
Proceedings of the National Academy of Sciences. 104:8526-8531
Helioxanthin is a natural product that inhibits the replication of a number of viruses. We found that a previously undescribed helioxanthin analogue, 8-1, exhibited potent anti-hepatitis B virus (HBV) activity with little cytotoxicity. 8-1 suppressed
Ribavirin and mycophenolic acid markedly potentiate the anti-hepatitis B virus activity of entecavir
Publikováno v:
Antiviral Research. 73:192-196
MPA [the active metabolite of the immuno-suppressive agent CellCept] and ribavirin markedly potentiate the anti-HBV activity of the guanine-based nucleoside analogue entecavir (ETV) against both wild-type HBV and a lamivudine-resistant variant. Ribav
Publikováno v:
Journal of Clinical Virology. 34:S147-S150
All the approved chemotherapeutic drugs for the treatment of HBV hepatitis are nucleoside analogs targeting on HBV DNA polymerase. Drugs targeting on other viral unique targets are needed. A new class of chemicals with novel action against HBV replic
Autor:
Robert Snoeck, Pieter Leyssen, Graciela Andrei, Johan Neyts, Christophe Pannecouque, Dana Hocková, Lieve Naesens, Erik De Clercq, Antonín Holý, Chunxiao Ying, Jan Balzarini
Publikováno v:
Nucleosides, Nucleotides & Nucleic Acids. 24:331-341
Three acyclic nucleoside phosphonates (ANPs) have been formally approved for clinical use in the treatment of 1) cytomegalovirus retinitis in AIDS patients (cidofovir, by the intravenous route), 2) chronic hepatitis B virus (HBV) infections (adefovir
Publikováno v:
Current Medicinal Chemistry -Anti-Infective Agents. 2:227-240
Publikováno v:
Journal of Virological Methods. 81:155-158
The use of digoxigenin-labelled probes was studied for quantitation of HBV-DNA during antiviral drug evaluation. Digoxigenin (dig)-labelled probes were generated either via incorporation of dig-dUTP in a polymerase chain reaction (PCR) or a random pr
Publikováno v:
Journal of Cancer Research and Therapeutics, Vol 12, Iss 8, Pp 264-267 (2016)
Objective: X-ray cross-complementing groups 1 (XRCC1) rs1799782 C>T polymorphisms and colorectal cancer susceptibility were not clear. The purpose of this study was to evaluate the association between XRCC1 rs1799782 C>T polymorphisms and colorectal